LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

Option Care Health Inc

Închisă

SectorSănătate

32.36 1.51

Rezumat

Modificarea prețului

24h

Curent

Minim

32.34

Maxim

32.66

Indicatori cheie

By Trading Economics

Venit

1.3M

52M

Vânzări

19M

1.4B

P/E

Medie Sector

28.643

108.767

Marjă de profit

3.611

Angajați

8,000

EBITDA

53M

156M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+21.69% upside

Dividende

By Dow Jones

Următoarele câștiguri

28 apr. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

1.3B

5.9B

Deschiderea anterioară

30.85

Închiderea anterioară

32.36

Sentimentul știrilor

By Acuity

63%

37%

292 / 352 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Option Care Health Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 feb. 2026, 23:53 UTC

Acțiuni populare

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 feb. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

28 feb. 2026, 21:36 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 15:20 UTC

Câștiguri

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 feb. 2026, 14:43 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 14:38 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 feb. 2026, 13:47 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 13:44 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 feb. 2026, 13:14 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 feb. 2026, 02:32 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 feb. 2026, 02:00 UTC

Achiziții, Fuziuni, Preluări

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 feb. 2026, 02:00 UTC

Achiziții, Fuziuni, Preluări

Six Months, 9 Offers and $81 Billion. How -2-

28 feb. 2026, 00:01 UTC

Achiziții, Fuziuni, Preluări

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 feb. 2026, 23:46 UTC

Achiziții, Fuziuni, Preluări

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 feb. 2026, 23:33 UTC

Achiziții, Fuziuni, Preluări

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 feb. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

27 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

27 feb. 2026, 21:30 UTC

Câștiguri

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 feb. 2026, 21:30 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 feb. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 feb. 2026, 21:17 UTC

Câștiguri

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 feb. 2026, 21:10 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 feb. 2026, 21:09 UTC

Achiziții, Fuziuni, Preluări

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 feb. 2026, 21:00 UTC

Câștiguri

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 feb. 2026, 20:31 UTC

Achiziții, Fuziuni, Preluări

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

27 feb. 2026, 20:24 UTC

Market Talk

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

27 feb. 2026, 20:23 UTC

Market Talk

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

27 feb. 2026, 20:12 UTC

Market Talk

Nike Seen With Further Challenges in China -- Market Talk

27 feb. 2026, 19:44 UTC

Market Talk

Gold Caps Historic Month -- Market Talk

27 feb. 2026, 19:39 UTC

Câștiguri

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

Comparație

Modificare preț

Option Care Health Inc Așteptări

Obiectiv de preț

By TipRanks

21.69% sus

Prognoză pe 12 luni

Medie 39.5 USD  21.69%

Maxim 43 USD

Minim 37 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOption Care Health Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

9

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

31.11 / 32.41Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Neutral Evidence

Termen lung

Strong Bullish Evidence

Sentiment

By Acuity

292 / 352 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Option Care Health Inc

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
help-icon Live chat